Search

Search Constraints

You searched for: Author/Creator Mahlangu, Johnny

Search Results

2. BAY 81‐8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years. (23rd March 2020)

3. Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non‐interventional study in a real‐world setting. Issue 2 (6th February 2019)

4. Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi‐centre, non‐interventional study. Issue 6 (8th October 2018)

5. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. (29th October 2020)

6. Cover Image. Issue 6 (13th November 2021)

9. Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. Issue 3 (March 2023)